AMX0035
A35-009
Phase 3 small_molecule completed
Quick answer
AMX0035 for Progressive Supranuclear Palsy is a Phase 3 program (small_molecule) at Amylyx Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amylyx Pharmaceuticals
- Indication
- Progressive Supranuclear Palsy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed